Princeton Capital Management’s Novo Nordisk NVO Stock Holding History

Princeton Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.17M	Sell	16,993 -8,675	-34%	-$599K	0.35%	44
2025 Q1	$1.78M	Sell	25,668 -22,619	-47%	-$1.57M	0.63%	26
2024 Q4	$4.15M	Sell	48,287 -753	-2%	-$64.8K	1.29%	16
2024 Q3	$5.84M	Buy	49,040 +183	+0.4%	+$21.8K	1.84%	13
2024 Q2	$6.97M	Buy	48,857 +342	+0.7%	+$48.8K	2.27%	10
2024 Q1	$6.23M	Buy	48,515 +453	+0.9%	+$58.2K	2.25%	11
2023 Q4	$4.97M	Buy	48,062 +2,806	+6%	+$290K	2%	15
2023 Q3	$4.12M	Sell	45,256 -9,454	-17%	-$860K	1.9%	14
2023 Q2	$4.43M	Sell	54,710 -1,478	-3%	-$120K	1.84%	18
2023 Q1	$4.47M	Sell	56,188 -6,808	-11%	-$542K	1.91%	16
2022 Q4	$4.26M	Sell	62,996 -8,034	-11%	-$544K	1.89%	16
2022 Q3	$3.54M	Buy	71,030 +350	+0.5%	+$17.4K	1.55%	20
2022 Q2	$3.94M	Buy	70,680 +1,610	+2%	+$89.7K	1.53%	19
2022 Q1	$3.84M	Sell	69,070 -18	-0%	-$999	1.19%	25
2021 Q4	$3.87M	Buy	69,088 +288	+0.4%	+$16.1K	1.11%	27
2021 Q3	$3.3M	Sell	68,800 -770	-1%	-$37K	1.05%	29
2021 Q2	$2.91M	Buy	69,570 +1,432	+2%	+$60K	0.9%	35
2021 Q1	$2.3M	Sell	68,138 -888	-1%	-$29.9K	0.78%	39
2020 Q4	$2.41M	Buy	69,026 +2,468	+4%	+$86.2K	0.86%	35
2020 Q3	$2.31M	Buy	66,558 +2,574	+4%	+$89.4K	0.93%	33
2020 Q2	$2.1M	Buy	63,984 +1,270	+2%	+$41.6K	0.93%	33
2020 Q1	$1.94M	Sell	62,714 -1,746	-3%	-$54.1K	1.01%	33
2019 Q4	$2.04M	Buy	64,460 +124	+0.2%	+$3.92K	0.91%	30
2019 Q3	$1.66M	Sell	64,336 -906	-1%	-$23.4K	0.81%	33
2019 Q2	$1.67M	Sell	65,242 -850	-1%	-$21.7K	0.81%	34
2019 Q1	$1.73M	Sell	66,092 -1,504	-2%	-$39.3K	0.87%	31
2018 Q4	$1.56M	Sell	67,596 -28,450	-30%	-$655K	0.91%	30
2018 Q3	$2.26M	Sell	96,046 -4,998	-5%	-$118K	0.94%	29
2018 Q2	$2.33M	Buy	101,044 +560	+0.6%	+$12.9K	1.01%	29
2018 Q1	$2.47M	Sell	100,484 -3,826	-4%	-$94.2K	1.1%	29
2017 Q4	$2.8M	Buy	+104,310	New	+$2.8M	1.25%	27